A major advance for targeting DNA for cancer treatment was the discovery that camptothecin (CPT), a natural product identified by Wall and Wani[1] in a screen for natural products with anti-cancer activity, targeted DNA topoisomerase 1 (Top1)[2]. This evidence concerns the gene TOP1 and cancer.